U.S. Marine and Shipping Stock News

NasdaqCM:RPID
NasdaqCM:RPIDLife Sciences

Pioneer Power Solutions And 2 Other Penny Stocks Worth Watching

In the last week, the U.S. market has stayed flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% per annum in the coming years. Amidst these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks may be an outdated term, but they still represent a valuable investment area; when backed by strong financials and balance sheet strength, these smaller...
NYSE:EBF
NYSE:EBFCommercial Services

Unveiling 3 Undiscovered Gems in the US Market

The United States market has experienced a flat performance over the last week but has seen a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals and growth potential can be key to uncovering hidden opportunities in the market.
NYSE:MANE
NYSE:MANEPharmaceuticals

Veradermics Hair Loss Trial Success Spurs Funding Plans For VDPHL01

Veradermics (NYSE:MANE) reported positive topline data from its pivotal Phase 2/3 trial of VDPHL01, an investigational non-hormonal oral treatment for pattern hair loss. The company framed VDPHL01 as a potential first in class oral option that could lead to the first FDA approval for a non-hormonal hair loss pill in nearly 30 years. Following the clinical update, Veradermics launched a proposed public offering tied to this stage of clinical and corporate progress. Veradermics focuses on...
NYSE:KOF
NYSE:KOFBeverage

3 Reliable Dividend Stocks To Consider With At Least 3.1% Yield

In the last week, the United States market has stayed flat, yet it is up 30% over the past year with earnings expected to grow by 16% per annum over the next few years. In such a dynamic environment, reliable dividend stocks with yields of at least 3.1% can offer investors a steady income stream and potential for long-term growth.
NasdaqGS:COLM
NasdaqGS:COLMLuxury

Columbia Sportswear (COLM) Valuation Check After Recent Share Price Rebound

Why Columbia Sportswear (COLM) is on investors’ radar today Columbia Sportswear (COLM) is back in focus after recent share price moves, with the stock showing mixed short term performance while longer term returns remain under pressure, prompting fresh questions about valuation and fundamentals. See our latest analysis for Columbia Sportswear. At a share price of $61.08, Columbia Sportswear has a 30 day share price return of 11.85% and a 90 day share price return of 13.36%. However, the 5...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Is It Time To Reassess Medpace Holdings (MEDP) After The Recent 20% Share Price Slide?

If you are wondering whether Medpace Holdings at around US$421 per share is still offering value after a strong multi year run, the key is to look past the headline price and into what buyers are actually paying for the business. The stock has recently seen a 20.3% decline over 7 days and a 6.6% decline over 30 days, although the 1 year return sits at 41.3% and the 3 year return at 104.1%. Recent coverage has focused on Medpace as a contract research organization supporting clinical...
NYSE:ETR
NYSE:ETRElectric Utilities

A Look At Entergy (ETR) Valuation After Strong 1‑Year Return And Capital Investment Plans

Entergy’s recent performance snapshot Entergy (ETR) has attracted fresh attention after recent share moves, with the stock showing a 1‑month return of 3.2%, a 3‑month return of 17.5%, and a 1‑year total return of 36.9%. See our latest analysis for Entergy. Recent trading has been relatively steady, with the latest move a small 1 day share price decline of 0.18%. However, the 90 day share price return of 17.46% and 1 year total shareholder return of 36.97% indicate that momentum has been...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics Call Puts Zovegalisib Breast Cancer Prospects In Focus

Relay Therapeutics scheduled a special call to present new clinical data on its Zovegalisib triplet therapy in breast cancer. The company plans to discuss the combination treatment results and their implications for its development programs. The announcement focuses on Zovegalisib in a triplet regimen, which may be relevant for investors following Relay Therapeutics drug pipeline. Relay Therapeutics, listed as NasdaqGM:RLAY, is drawing attention with a dedicated update on Zovegalisib, a key...
NYSE:GRND
NYSE:GRNDInteractive Media and Services

Is Grindr's Chemsex Support Initiative Reframing Its Social Impact Narrative For Investors (GRND)?

In April 2026, Grindr for Equality launched “Out in the Open,” a new content series on chemsex and mental health, created with UK non-profit You Are Loved and other LGBTQ+ support organizations, and backed by new research on drug use, stigma, and community needs. The initiative also updates in-app resources to signpost users directly to support services, underscoring Grindr’s effort to embed social impact and community care into the core app experience. We’ll now explore how this focus on...
NYSE:CXM
NYSE:CXMSoftware

Assessing Sprinklr (CXM) Valuation After Prolonged Share Price Weakness

Sprinklr (CXM) has been drawing attention after recent share price volatility, with the stock last closing at US$5.10. For investors, that move invites a closer look at its current business and valuation profile. See our latest analysis for Sprinklr. That recent move comes after a weak run. The 30 day share price return is 13.27%, while the year to date share price return shows a 30.33% decline, alongside a 1 year total shareholder return of a 33.59% decline and a 3 year total shareholder...
NYSE:BAP
NYSE:BAPBanks

Assessing Credicorp (NYSE:BAP) Valuation After Recent Losing Streak And Cooling Momentum

Why Credicorp is on investors’ radar today Credicorp (BAP) is drawing fresh attention after recent trading left the shares about 10% lower over the past 3 months, prompting investors to reassess its valuation and long term return profile. See our latest analysis for Credicorp. The recent 1 week share price return of 4.7% decline and 3 month share price return of 10.2% decline contrast with a much stronger 1 year total shareholder return of 69.3%. This suggests that momentum has cooled...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Is It Too Late To Consider Popular (BPOP) After Its Strong Multi Year Share Price Run?

Investors may be wondering if Popular at around US$150.62 is still offering value after a strong run, or if most of the easy gains are already on the table. The stock has returned 1.4% over the last 7 days, 15.8% over the past month, 19.6% year to date, 59.5% over 1 year, 188.1% over 3 years and 128.7% over 5 years, which can change how the market views both its potential and its risks. Recent coverage has focused on Popular's position within the US banking sector and how investors are...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

Is It Too Late To Consider Construction Partners (ROAD) After A 50% One Year Rally?

If you are wondering whether Construction Partners at around US$120.79 is offering good value or asking too much, you are not alone in questioning what is really priced into the stock. The share price has moved around recently, with a 5.3% decline over the last 7 days, a 10.8% gain over 30 days, a 7.7% return year to date and a 49.9% return over the past year. This adds to a very large 3-year gain of 369.8% and a 5-year return of 274.4%. These swings have kept Construction Partners on many...
NYSE:HLX
NYSE:HLXEnergy Services

Is It Time To Reassess Helix Energy Solutions Group (HLX) After Its Strong Multi Year Run?

Wondering if Helix Energy Solutions Group at around US$9.93 is offering good value right now? This article breaks down what the current price might be implying about the business. The stock has returned 8.8% over the last 7 days, while the 30 day return sits at a 1.7% decline and the year to date gain is 55.2%, with a 61.5% return over 1 year, 39.3% over 3 years and 123.6% over 5 years. Recent coverage has focused on Helix Energy Solutions Group as part of broader conversations around the...
NYSE:W
NYSE:WSpecialty Retail

Is It Too Late To Consider Wayfair (W) After Its Sharp Share Price Swings?

This article examines whether Wayfair, at around US$75.77, may still be offering value or if most of the potential upside is already reflected in the price, and breaks down what the current price might be implying. The stock has experienced notable volatility, with a 6.6% decline over the past week, a 6.0% gain over the last 30 days, a 28.9% decline year to date, and a 144.3% return over the past year. Recent coverage has focused on Wayfair's position in online home retail and how investors...
NYSE:AMR
NYSE:AMRMetals and Mining

Alpha’s Heavy Buybacks Amid a Net Loss Could Be A Game Changer For Alpha Metallurgical Resources (AMR)

Alpha Metallurgical Resources recently reported a first-quarter 2026 net loss driven by lower volumes and higher costs, including a planned equipment-upgrade outage and increased diesel prices, while also confirming that from January 1 to March 31, 2026 it repurchased 87,000 shares for US$17.5 million. With the latest tranche, Alpha has now completed the repurchase of 6,965,449 shares for about US$1.16 billion under its March 2022 authorization, meaning a very large portion of its share...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Is It Too Late To Consider Marex Group (MRX) After Its Strong Year To Date Rally?

If you are wondering whether Marex Group's current share price reflects its true worth, this article walks through the key numbers that matter for value focused investors. The stock recently closed at US$53.12, with returns of 7.4% over 7 days, 23.6% over 30 days, 40.0% year to date, and 20.8% over 1 year. These figures put recent price moves front and center in any valuation discussion. Recent coverage has focused on Marex Group as a listed player in the capital markets space and on how its...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Is Viking Therapeutics (VKTX) Still Attractive After Recent Share Price Swings?

Wondering if Viking Therapeutics at around US$33 is still offering value or if most of the story is already priced in? This article focuses squarely on what the numbers say about its valuation. The stock has seen a mix of shorter term weakness and longer term strength, with a 7.2% decline over the past week, a 1.4% gain over the last 30 days, a 6.9% decline year to date, and a 27.2% return over the past year. Recent attention on Viking Therapeutics has been shaped by ongoing developments...
NYSE:BFH
NYSE:BFHConsumer Finance

A Look At Bread Financial Holdings (BFH) Valuation After Strong Recent Share Price Gains

Why Bread Financial Holdings (BFH) is on investors’ radar Bread Financial Holdings (BFH) has drawn attention after a strong share price move, with the stock up about 22% over the past month and 27% over the past 3 months. That performance, combined with a value score of 5 and an intrinsic discount estimate of about 39%, is prompting investors to take a closer look at how the business and its current valuation line up. See our latest analysis for Bread Financial Holdings. Short term momentum...
NYSE:BYD
NYSE:BYDHospitality

A Look At Boyd Gaming (BYD) Valuation After Q1 2026 Earnings Miss And Flat Sales

Boyd Gaming (BYD) is back in focus after its Q1 2026 report showed flat year on year sales, an adjusted earnings per share miss, and fresh commentary on regional growth, cost pressures, and ongoing construction in Las Vegas. See our latest analysis for Boyd Gaming. Boyd Gaming shares have climbed, with a 9.19% 1 month share price return and a 27.50% 1 year total shareholder return. This suggests that recent earnings, buybacks, and capital projects are influencing how the market views future...
NasdaqGM:VWAV
NasdaqGM:VWAVAerospace & Defense

Assessing VisionWave Holdings (VWAV) Valuation After New US$44.15m Shelf Registration Filing

Capital raise plans put VisionWave Holdings (VWAV) in focus VisionWave Holdings (VWAV) has drawn fresh attention after filing a shelf registration for up to US$44.15m of common stock, a move that gives the company flexibility to tap equity markets. See our latest analysis for VisionWave Holdings. The shelf registration and recent board appointment come after a sharp 38.98% 90 day share price decline and a 43.14% 1 year total shareholder return loss, even as the latest close sits at US$6.34...
NYSE:STAG
NYSE:STAGIndustrial REITs

Is It Time To Reassess STAG Industrial (STAG) After Its Recent Share Price Recovery?

Wondering if STAG Industrial is offering fair value at around US$39.48, or if the current price is leaving something on the table for new investors. The stock has had a mixed run recently, with a 1% decline over the last 7 days, a 9.4% gain over the last 30 days, and returns of 6.9% year to date and 25.3% over the last year. Recent coverage has focused on STAG Industrial's position in the industrial real estate space and how investors are weighing it against wider REIT options. This context...